Usability and Ergonomic Evaluation of Self-Positioning System for Retinal Imaging
1 other identifier
interventional
16
1 country
1
Brief Summary
The purpose of the study "Usability and Ergonomic Evaluation of Self-Positioning System for Retinal Imaging" is to enable self-operation of a monitoring device in home-simulated environment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 15, 2017
CompletedFirst Posted
Study publicly available on registry
September 1, 2017
CompletedStudy Start
First participant enrolled
September 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2018
CompletedJune 13, 2019
June 1, 2019
4 months
August 15, 2017
June 12, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
spatial location of the pupil, during an eye examination
documentation of pupil location by a camera
1 year
Study Arms (1)
Usability and Ergonomic Evaluation of Self-Positioning System
EXPERIMENTALInterventions
Up to 60 Subjects will be evaluating for positioning accuracy and comfort by comparing different methods utilizing the PAF device. Some methods of positioning will be applied and compare for each usability factor X, Y, Z location, and fixation. The patient will be evaluated before pupil dilation. VA and ophthalmic diagnoses will be recorded. Pupil position will be recorded using 3 commercial off the shelf cameras when the subject is performing simple ergonomic tasks while looking at a screen presenting images. Each testing session will be limited 20 min long. Subjects will be able to rest within the testing session if required. Total session time per patient will not exceed 30 minutes.
Eligibility Criteria
You may qualify if:
- Age ≥ 65
- Able to understand and sign the informed consent form
- Ability to communicate verbally
- AMD (interim and advanced) or diabetic retinopathy (with and without DME)
You may not qualify if:
- Visual acuity \>=20/200 in the better eye
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sorasky Medical Center
Tel Aviv, Israel
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 15, 2017
First Posted
September 1, 2017
Study Start
September 30, 2017
Primary Completion
February 1, 2018
Study Completion
September 30, 2018
Last Updated
June 13, 2019
Record last verified: 2019-06